In the News

EHR alerts may help boost guideline-directed therapy for heart failure

An industry-funded cluster-randomized trial found that clinician alerts were associated with an over 40% increase in prescription of four recommended drug classes in patients with heart failure with reduced ejection fraction.

Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low

A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.

MKSAP Quiz: Evaluation for dyspnea

This week's quiz asks readers to determine the most appropriate treatment for a 42-year-old man with hypertrophic cardiomyopathy who is experiencing dyspnea.

Presenting symptoms in low-risk outpatients not always associated with higher baseline CAD risk

Researchers performed a secondary analysis of the PROMISE trial to determine the relationship between coronary artery disease (CAD) symptoms at presentation and resulting processes of care, test results, and clinical outcomes.

ACP announces Internal Medicine Meeting 2022 speakers

This year's meeting features keynote speaker Quinn Capers, MD, on Thursday, April 28, and plenary speakers Mukta Panda, MD, MACP, and Tammy L. Lin, MD, MPH, FACP, on Saturday, April 30.

ACP's Job Placement Center provides career opportunities at Internal Medicine Meeting 2022

Physicians looking for a job may submit a job seeker's profile and/or upload their CV to reach participating employers.

Vote for your favorite entry

ACP Internist Weekly's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.